Venus Remedies Gains PIC/S GMP Approval for Robotic Syringe Facility

Venus Remedies announced that its robotic pre-filled syringe facility at the Baddi unit has been granted approval for good manufacturing practices (GMP) by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Venus Remedies announced in a statement that their pre-filled syringe (PFS) facility has received its inaugural Pharmaceutical Inspection Co-operation Scheme (PIC/S) accreditation.

"Securing the PIC/S GMP accreditation from Malaysia's NPRA is a significant milestone and a testament to our commitment to quality and technological innovation in pharmaceutical manufacturing," Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre, said.

Chaudhary further noted that "the major technological upgrades and investments we've made in our PFS facility over recent years have culminated in this recognition, reinforcing our team's dedication and excellence."

The high compliance standards and world-class quality control measures at Venus Remedies' Baddi facility were highlighted by the approval process completed within six months of a rigorous audit in April 2024.

Aditi Chaudhary, president of International Business at Venus Remedies, said, "the PIC/S GMP accreditation is a testament to the dedication and expertise of our teams across the globe. With this achievement, we are well-positioned to extend our international footprint and bring high-quality, life-saving medicines to more markets, thus ensuring better access to healthcare for all."